NeoChord Inc. Obtains Exclusive Rights to State-of-the-Art, Award-Winning ‘Augmented Reality’ Imaging Technology From Western University’s Robarts Research Institute  
10/2/2012 10:22:52 AM

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--NeoChord, a medical device company focused on minimally invasive mitral valve repair, announced today that it has obtained the exclusive rights to state-of-the-art ‘augmented reality’ imaging technology from the Robarts Research Institute (RRI) at Western University, London, Ontario, Canada. Financial terms of the Licensing Agreement were not disclosed.